Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01729494Phase 4Completed
A Phase 4 trial of belatacept in kidney transplant rejection, sponsored by University of Cincinnati. Started Sep 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01729494.